Powassan virus, a rare tick-borne illness, has reached a record high in the United States, with 76 reported cases in 2025. The virus, first identified in 1958, is transmitted to humans through the bite of infected deer ticks or woodchuck ticks. Public health experts are concerned about its rapid transmission capabilities, which can occur as little as 15 minutes after an infected tick bite.
This rapid transmission contrasts sharply with illnesses like Lyme disease, which typically require 36 to 48 hours of attachment for transmission. Powassan virus has an incubation period of one to four weeks before symptoms appear, though some infected individuals may remain asymptomatic. Initial symptoms can include fever, headache, vomiting, and weakness.
The virus can lead to severe neurological complications such as encephalitis, an inflammation of the brain, and meningitis, inflammation of the spinal cord membranes. In severe cases, patients may experience confusion, loss of coordination, speech difficulties, and seizures. Approximately 10% of severe Powassan virus cases are fatal, and many survivors are left with long-term neurological issues.
The prevalence of Powassan virus typically peaks from late spring through mid-fall, coinciding with increased tick populations and outdoor activities. While the virus remains rare compared to other tick-borne illnesses, its potential for rapid progression and severe outcomes is a significant clinical concern. There are currently no specific vaccines or medications to treat Powassan virus; care is limited to supportive therapies. Experts caution that while anyone can contract severe illness, children, older adults, and immunocompromised individuals are at the highest risk.